단일 세포 멀티 오믹스 시장 - 세계 및 지역별 분석 : 제품 유형별, 샘플 유형별, 기술별, 용도별, 오믹스 유형별, 최종 사용자별, 국가별 - 분석 및 예측(2023-2033년)

“Global Single-Cell Multi-Omics Market to Reach $7.72 Billion by 2033.”

Industry Overview

The global single-cell multi-omics market is projected to reach $7.72 billion by 2033 from $1.43 billion in 2022, growing at a CAGR of 17.27% during the forecast period 2023-2033. The market is driven by factors such as a rise in the number of large-scale genomics studies leveraging single-cell RNA sequencing (Sc-RNA), use of the single-cell multi-omics approach for screening and diagnostics of diseases leading to a shift toward personalized medicine, and the increasing use of single-cell multi-omics for drug development.

Market Lifecycle Stage

The global single-cell multi-omics market is developing. The global single-cell multi-omics market has witnessed several collaborations among the market players. The collaborations are aimed at combining capabilities, expanding the customer base, and marketing, among others.

The opportunity for growth of the global single-cell multi-omics market lies in expansion into new research applications, such as single-cell metabolomics.

Impact of COVID-19

The COVID-19 pandemic has significantly impacted the world's healthcare sector, especially the single-cell multi-omics sector. The pandemic has caused changes in research priorities, supply chain interruptions, and regulatory process modifications that may have had an impact on the operations and activities of single-cell multi-omics.

The future impact of COVID-19 on the demand and supply across the global single-cell multi-omics market depends on the abilities of stakeholders to withstand unforeseeable scenarios in the future. The intensity of impact due to COVID-19 in the future will depend on the current efforts being made by companies to equip their supply chains with the necessary components and processes to remain responsive.

Market Segmentation:

Segmentation 1: by Sample Type

• Animal Sample
• Human Sample
• Microbial Sample

The global single-cell multi-omics market (by sample type) is expected to be dominated by the human sample segment.

Segmentation 2: by Techniques

• Single-Cell Isolation and Dispensing
• Single-Cell Analysis

The global single-cell multi-omics market (by techniques) is expected to be dominated by single-cell isolation and dispensing.

Segmentation 3: By Omics Type

• Single-Cell Transcriptomics
• Single-Cell Genomics
• Single-Cell Proteomics

The global single-cell multi-omics market (by omics type) is expected to be dominated by single-cell transcriptomics.

Segmentation 4: By Product Type

• Kits and Consumables
• Instruments
• Software

The global single-cell multi-omics market (by product type) is expected to be dominated by kits and consumables.

Segmentation 5: By Applications

• Clinical Research
• Translational Research
• Synthetic Biology

The global single-cell multi-omics market (by application) is expected to be dominated by clinical research.

Segmentation 6: By End User

• Biopharmaceutical and Biotech Companies
• Academic and Research Institutions
• Contract Research Organizations (CROs)

The global single-cell multi-omics market (by end user) is expected to be dominated by academic and research institutions.

Segmentation 7: by Region

• North America - U.S., Canada

• Europe - Germany, U.K., France, Italy, Spain, and Rest-of-Europe

• Asia-Pacific - China, Japan, India, Australia, Singapore, and Rest-of-Asia-Pacific

• Latin America - Brazil, Mexico, and Rest-of-Latin America

• Rest-of-the-World

The global single-cell multi-omics market (by region) is dominated by the North America region.

Recent Developments in Global Single-Cell Multi-Omics Market

• In February 2023, Singleron Biotechnologies and Macrogen Europe announced a strategic alliance to deliver outstanding single-cell multi-omics sequencing solutions, and they combined their strengths.

• In February 2023, Becton, Dickinson and Company announced a new instrument for single-cell multi-omics analysis that would enable scientists to run high-throughput studies without sacrificing sample integrity - potentially accelerating time to discovery across a wide range of disciplines, including immunology, genetic disease research, and cancer and chronic disease research.

• In December 2022, 10x Genomics, Inc. announced the first commercial shipments of its Xenium platform for in situ analysis. Xenium is the next generation of targeted spatial profiling of genes and proteins at subcellular resolution.

• In March 2023, Mission Bio partnered with the National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT), leveraging its Tapestri Platform to improve analytical assays and cell manufacturing processes.

• In December 2022, Mission Bio partnered with Abiosciences to co-develop bioinformatics packages for translational and clinical research applications in hematological cancers in China. The goal is to combine Mission Bio's single-cell DNA and multi-omics capabilities with Abiosciences' artificial intelligence technology to uncover new disease signatures and address therapeutic resistance.

Demand - Drivers and Limitations

The following are the drivers for the global single-cell multi-omics market:

• Rising Number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (Sc-RNA)
• Use of Single-Cell Multi-Omics Approach for Screening and Diagnostics of Diseases Leading to Shift Toward Personalized Medicine
• Increasing Use of Single-Cell Multi-Omics for Drug Development
• Collaborations among Technology Providers and Life Sciences Companies for Accelerating the Research in Single-Cell Multi-Omics

The market is expected to face some limitations as well due to the following challenges:

• High Cost of Single-Cell Analysis and Sequencing
• Limited Availability of Large Online Data Storage and Analysis Platforms

How can this report add value to an organization?

• Growth/Marketing Strategy: The global single-cell multi-omics market has seen major development by key players operating in the market, such as new offerings, partnerships, collaboration, and joint ventures.

• Competitive Strategy: The global single-cell multi-omics market has witnessed growth in recent years; as the field of single-cell multi-omics grows, it has witnessed increased collaboration between researchers, academic institutions, and industry partners to drive innovation and commercialization of these technologies. Single-cell multi-omics technologies are already being used in a variety of applications, such as cancer research, immunology, and neuroscience. As the technologies continue to improve, they may be applied to other areas of research, such as developmental biology and stem cell research.

Key Companies Profiled:

Table of Contents

1 Market

• 1.1 Global Market Outlook
  • 1.1.1 Product Definition
  • 1.1.2 Inclusion and Exclusion Criteria
• 1.2 Market Overview
  • 1.2.1 Key Findings
  • 1.2.2 Current Market Scenario
    • 1.2.2.1 For Researchers
    • 1.2.2.2 For Diagnostics
• 1.3 Industry Outlook
  • 1.3.1 Regulatory Framework
  • 1.3.2 Patent Analysis
    • 1.3.2.1 Awaited Technological Developments
    • 1.3.2.2 Patent Filing Trend (by Country)
    • 1.3.2.3 Patent Filing Trend (by Year)
  • 1.3.3 Key Trends
    • 1.3.3.1 Advancements in Imaging Techniques for Single-Cell Sequencing
    • 1.3.3.2 Use of Artificial Intelligence (AI) and Machine Learning (ML) in Single-Cell Multi-Omics
    • 1.3.3.3 Increased Development of Advanced Solution Based on Single-Cell Technology
  • 1.3.4 Opportunity Assessment
  • 1.3.5 Product Benchmarking
  • 1.3.6 Clinical Trials
• 1.4 COVID-19 Impact
  • 1.4.1 Pre-COVID-19
  • 1.4.2 During COVID-19
  • 1.4.3 Post COVID-19
• 1.5 Business Dynamics
  • 1.5.1 Impact Analysis
  • 1.5.2 Business Drivers
    • 1.5.2.1 Rising Number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (Sc-RNA)
    • 1.5.2.2 Use of Single-Cell Multi-Omics Approach for Screening and Diagnostics of Diseases Leading to Shift Toward Personalized Medicine
    • 1.5.2.3 Increasing Use of Single-Cell Multi-Omics for Drug Development
    • 1.5.2.4 Collaborations among Technology Providers and Life Sciences Companies for Accelerating the Research in Single-Cell Multi-Omics
  • 1.5.3 Business Restraints
    • 1.5.3.1 High Cost of Single-Cell Analysis and Sequencing
    • 1.5.3.2 Limited Availability of Large Online Data Storage and Analysis Platforms
  • 1.5.4 Business Opportunities
    • 1.5.4.1 Expansion into New Research Applications, Such as Single-Cell Metabolomics
    • 1.5.4.2 Increasing Adoption of Genomic-Based Medicine in Emerging Nations

2 Global Single-Cell Multi-Omics Market (by Product Type)

• 2.1 Overview
• 2.2 Instruments
• 2.3 Kits and Consumables
• 2.4 Software

3 Global Single-Cell Multi-Omics Market (by Sample Type)

• 3.1 Overview
• 3.2 Human Samples
  • 3.2.1 Cancer Tissues
  • 3.2.2 Stem Cells
  • 3.2.3 Brain Cells
  • 3.2.4 Immune Cells
  • 3.2.5 Other Samples
• 3.3 Animal Samples
• 3.4 Microbial Samples

4 Global Single-Cell Multi-Omics Market (by Techniques)

• 4.1 Overview
• 4.2 Single-Cell Isolation and Dispensing
  • 4.2.1 Fluorescence-Activated Cell Sorting (FACS)
  • 4.2.2 Manual Cell Picking
  • 4.2.3 Magnetic-Activated Cell Sorting (MACS)
  • 4.2.4 Laser Capture Microdissection
  • 4.2.5 Random Seeding
  • 4.2.6 Microfluidics
  • 4.2.7 Others
• 4.3 Single-Cell Analysis
  • 4.3.1 Mass Cytometry
  • 4.3.2 Polymerase Chain Reaction
  • 4.3.3 Next-Generation Sequencing
  • 4.3.4 Mass Spectrometry
  • 4.3.5 Others

5 Global Single-Cell Multi-Omics Market (by Applications)

• 5.1 Overview
• 5.2 Clinical Research
  • 5.2.1 Oncology
  • 5.2.2 Immunology
  • 5.2.3 Neurology
  • 5.2.4 Cell Therapy
  • 5.2.5 Cell Biology
  • 5.2.6 Others
• 5.3 Translational Research
• 5.4 Synthetic Biology

6 Global Single-Cell Multi-Omics Market (by Omics Type)

• 6.1 Overview
• 6.2 Single-Cell Genomics
• 6.3 Single-Cell Proteomics
• 6.4 Single-Cell Transcriptomics

7 Global Single-Cell Multi-Omics Market (by End User)

• 7.1 Opportunity Assessment
• 7.2 Biopharmaceutical and Biotech Companies
• 7.3 Research and Academic Laboratories
• 7.4 Contract Research Organizations (CROs)

8 Global Single-Cell Multi-Omics Market (by Region)

• 8.1 North America
  • 8.1.1 Key Findings and Opportunity Assessment
  • 8.1.2 Market Dynamics
    • 8.1.2.1 Impact Analysis
  • 8.1.3 Market Sizing and Forecast
    • 8.1.3.1 North America Single-Cell Multi-Omics Market (by Country)
      • 8.1.3.1.1 U.S.
      • 8.1.3.1.2 Canada
• 8.2 Europe
  • 8.2.1 Key Findings and Opportunity Assessment
  • 8.2.2 Market Dynamics
    • 8.2.2.1 Impact Analysis
  • 8.2.3 Market Sizing and Forecast
    • 8.2.3.1 Europe Single-Cell Multi-Omics Market (by Country)
      • 8.2.3.1.1 Germany
      • 8.2.3.1.2 Italy
      • 8.2.3.1.3 U.K.
      • 8.2.3.1.4 Spain
      • 8.2.3.1.5 France
      • 8.2.3.1.6 Rest-of-Europe
• 8.3 Asia-Pacific
  • 8.3.1 Key Findings and Opportunity Assessment
  • 8.3.2 Market Dynamics
    • 8.3.2.1 Impact Analysis
  • 8.3.3 Sizing and Forecast Analysis
    • 8.3.3.1 Asia-Pacific Single-Cell Multi-Omics Market (by Country)
      • 8.3.3.1.1 China
      • 8.3.3.1.2 Japan
      • 8.3.3.1.3 India
      • 8.3.3.1.4 Singapore
      • 8.3.3.1.5 Australia
      • 8.3.3.1.6 Rest-of-Asia-Pacific
• 8.4 Latin America
  • 8.4.1 Key Findings and Opportunity Assessment
  • 8.4.2 Market Dynamics
    • 8.4.2.1 Impact Analysis
  • 8.4.3 Sizing and Forecast Analysis
    • 8.4.3.1 Latin America Single-Cell Multi-Omics Market (by Country)
      • 8.4.3.1.1 Brazil
      • 8.4.3.1.2 Mexico
      • 8.4.3.1.3 Rest-of-Latin America
• 8.5 Rest-of-the-World
  • 8.5.1 Key Findings
  • 8.5.2 Market Dynamics
    • 8.5.2.1 Impact Analysis
  • 8.5.3 Market Sizing and Forecast

9 Markets - Competitive Benchmarking & Company Profiles

• 9.1 Competitive Benchmarking
  • 9.1.1 Key Strategies and Developments
    • 9.1.1.1 Funding Activities
    • 9.1.1.2 New Offerings
    • 9.1.1.3 Mergers and Acquisitions
    • 9.1.1.4 Partnership, Collaboration, and Business Expansion
  • 9.1.2 Market Share Analysis
  • 9.1.3 Growth Share Analysis
    • 9.1.3.1 By Application
    • 9.1.3.2 By Omics Type
    • 9.1.3.3 By Product Type
  • 9.1.4 Visual Graphics of the Companies
  • 9.1.5 Multi-Omics Ecosystem Active Players
• 9.2 Company Profiles
  • 9.2.1 10x Genomics, Inc.
    • 9.2.1.1 Company Overview
    • 9.2.1.2 Role of 10x Genomics, Inc. in the Global Single-Cell Multi-Omics Market
    • 9.2.1.3 Financials
    • 9.2.1.4 Recent Developments
    • 9.2.1.5 Analyst Perspective
  • 9.2.2 Becton, Dickinson and Company
    • 9.2.2.1 Company Overview
    • 9.2.2.2 Role of Becton, Dickinson and Company in the Global Single-Cell Multi-Omics Market
    • 9.2.2.3 Financials
    • 9.2.2.4 Recent Developments
    • 9.2.2.5 Analyst Perspective
  • 9.2.3 BICO GROUP AB (PUBL)
    • 9.2.3.1 Company Overview
    • 9.2.3.2 Role of BICO GROUP AB (PUBL)in the Global Single-Cell Multi-Omics Market
    • 9.2.3.3 Financials
    • 9.2.3.4 Analyst Perspective
  • 9.2.4 Bio-Rad Laboratories, Inc.
    • 9.2.4.1 Company Overview
    • 9.2.4.2 Role of Bio-Rad Laboratories, Inc. in the Global Single-Cell Multi-Omics Market
    • 9.2.4.3 Financials
    • 9.2.4.4 Analyst Perspective
  • 9.2.5 BGI Group
    • 9.2.5.1 Company Overview
    • 9.2.5.2 Role of BGI Group in the Global Single-Cell Multi-Omics Market
    • 9.2.5.3 Financials
    • 9.2.5.4 Analyst Perspective
  • 9.2.6 Illumina Inc.
    • 9.2.6.1 Company Overview
    • 9.2.6.2 Role of Illumina Inc. in the Global Single-Cell Multi-Omics Market
    • 9.2.6.3 Financials
    • 9.2.6.4 Analyst Perspective
  • 9.2.7 Fluidigm Corporation (Standard Bio Tools)
    • 9.2.7.1 Company Overview
    • 9.2.7.2 Role of Fluidigm Corporation in the Global Single-Cell Multi-Omics Market
    • 9.2.7.3 Financials
    • 9.2.7.4 Recent Developments
    • 9.2.7.5 Analyst Perspective
  • 9.2.8 Menarini Group
    • 9.2.8.1 Company Overview
    • 9.2.8.2 Role of Menarini Group in the Global Single-Cell Multi-Omics Market
    • 9.2.8.3 Analyst Perspective
  • 9.2.9 Mission Bio
    • 9.2.9.1 Company Overview
    • 9.2.9.2 Role of Mission Bio in the Global Single-Cell Multi-Omics Market
    • 9.2.9.3 Recent Developments
    • 9.2.9.4 Analyst Perspective
  • 9.2.10 Nanostring Technologies, Inc.
    • 9.2.10.1 Company Overview
    • 9.2.10.2 Role of Nanostring Technologies, Inc. in the Global Single-Cell Multi-Omics Market
    • 9.2.10.3 Financials
    • 9.2.10.4 Analyst Perspective
  • 9.2.11 Namocell, Inc.
    • 9.2.11.1 Company Overview
    • 9.2.11.2 Role of Namocell, Inc. in the Global Single-Cell Multi-Omics Market
    • 9.2.11.3 Analyst Perspective
  • 9.2.12 PhenomeX,inc.
    • 9.2.12.1 Company Overview
    • 9.2.12.2 Role of PhenomeX,inc. in the Global Single-Cell Multi-Omics Market
    • 9.2.12.3 Financials
    • 9.2.12.4 Recent Developments
    • 9.2.12.5 Analyst Perspective
  • 9.2.13 QIAGEN NV
    • 9.2.13.1 Company Overview
    • 9.2.13.2 Role of QIAGEN NV in the Global Single-Cell Multi-Omics Market
    • 9.2.13.3 Financials
    • 9.2.13.4 Analyst Perspective
  • 9.2.14 Rarecells Diagnostics
    • 9.2.14.1 Company Overview
    • 9.2.14.2 Role of Rarecells Diagnostics in the Global Single-Cell Multi-Omics Market
    • 9.2.14.3 Analyst Perspective
  • 9.2.15 Scipio Bioscience
    • 9.2.15.1 Company Overview
    • 9.2.15.2 Role of Scipio Bioscience in the Global Single-Cell Multi-Omics Market
    • 9.2.15.3 Analyst Perspective
  • 9.2.16 Shilps Sciences
    • 9.2.16.1 Company Overview
    • 9.2.16.2 Role of Shilps Sciences in the Global Single-Cell Multi-Omics Market
    • 9.2.16.3 Analyst Perspective
  • 9.2.17 Singleron Biotechnologies
    • 9.2.17.1 Company Overview
    • 9.2.17.2 Role of Singleron Biotechnologies in the Global Single-Cell Multi-Omics Market
    • 9.2.17.3 Recent Developments
    • 9.2.17.4 Analyst Perspective
  • 9.2.18 Takara Bio Inc.
    • 9.2.18.1 Company Overview
    • 9.2.18.2 Role of Takara Bio Inc. in the Global Single-Cell Multi-Omics Market
    • 9.2.18.3 Financials
    • 9.2.18.4 Analyst Perspective
  • 9.2.19 Thermo Fisher Scientific Inc.
    • 9.2.19.1 Company Overview
    • 9.2.19.2 Role of Thermo Fisher Scientific Inc. in the Global Single-Cell Multi-Omics Market
    • 9.2.19.3 Financials
    • 9.2.19.4 Analyst Perspective
  • 9.2.20 Universal Sequencing Technology Corporation
    • 9.2.20.1 Company Overview
    • 9.2.20.2 Role of Universal Sequencing Technology Corporation in the Global Single-Cell Multi-Omics Market
    • 9.2.20.3 Analyst Perspective